Literature DB >> 20145387

Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis.

Seok-Yong Eum1, Ye-Jin Lee, Jin-Hong Min, Hyun-Kyung Kwak, Min-Sun Hong, Ji-Hye Kong, Soo-Hee Hwang, Seung-Kyu Park, Jason J Leblanc, Laura E Via, Clifton E Barry, Sang-Nae Cho.   

Abstract

BACKGROUND: We have previously reported that TNF-α levels correlate to total mycobacterial burden in tuberculosis (TB) patients.
OBJECTIVE: To characterize the dynamics of cytokine responses in TB patients during chemotherapy to identify potential surrogate markers for effective treatment.
METHODS: Following induction by culture filtrate proteins in whole blood, production patterns of TNF-α, IL-10, IFN-γ and IL-12 were measured in 23 non-multidrug-resistant (MDR)-TB and 16 MDR-TB patients and in 31 healthy controls. Rates of mycobacterial clearance from the sputum were then measured and compared.
RESULTS: Prior to the initiation of chemotherapy, TNF-α and IL-10 levels were significantly higher in TB patients than in healthy controls while IFN-γ and IL-12 levels were similar. During chemotherapy, the levels of all 4 cytokines increased. We evaluated these responses separately in patients that did and did not clear their sputum culture at 2 and 6 months. At 2 months, decreases in both IFN-γ and IL-12 correlated strongly with a successful early response, while after 6 months of therapy, when half (7/14) of MDR-TB patients were still sputum culture positive, downregulation of TNF-α was uniquely correlated with sputum conversion between the groups.
CONCLUSION: Our findings suggest the possibility that the regulation of TNF-α production in whole blood may be a more specific indicator of sputum conversion at 6 months than IFN-γ, IL-12 or IL-10 in MDR-TB patients.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20145387      PMCID: PMC2955738          DOI: 10.1159/000283687

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  29 in total

1.  Revised international definitions in tuberculosis control.

Authors: 
Journal:  Int J Tuberc Lung Dis       Date:  2001-03       Impact factor: 2.373

Review 2.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis.

Authors:  J-S Lee; C-H Song; C-H Kim; S-J Kong; M-H Shon; H-J Kim; J-K Park; T-H Paik; E-K Jo
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

Review 4.  Correlates of protective immunity to Mycobacterium tuberculosis in humans.

Authors:  J J Ellner; C S Hirsch; C C Whalen
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

5.  Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance.

Authors:  Rodrigo Ribeiro-Rodrigues; Tatiana Resende Co; John L Johnson; Fabiola Ribeiro; Moises Palaci; Ricardo T Sá; Ethel L Maciel; Fausto E Pereira Lima; Valderio Dettoni; Zahra Toossi; W Henry Boom; Reynaldo Dietze; Jerrold J Ellner; Christina S Hirsch
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

6.  Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens.

Authors:  H M Surcel; M Troye-Blomberg; S Paulie; G Andersson; C Moreno; G Pasvol; J Ivanyi
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

7.  Tumor necrosis factor-alpha and interleukin-10 in whole blood is associated with disease progression in pulmonary multidrug-resistant tuberculosis patients.

Authors:  Seok-Yong Eum; Bo-Young Jeon; Jin-Hong Min; Seung-Cheol Kim; Sungae Cho; Seung-Kyu Park; Sang-Nae Cho
Journal:  Respiration       Date:  2008-01-23       Impact factor: 3.580

8.  Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes.

Authors:  B J Johnson; D N McMurray
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

9.  Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection.

Authors:  R Appelberg; A G Castro; J Pedrosa; R A Silva; I M Orme; P Minóprio
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

10.  Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population.

Authors:  Rabia Hussain; Arnawaz Kaleem; Firdaus Shahid; Maqboola Dojki; Bushra Jamil; Hammad Mehmood; Ghaffar Dawood; Hazel M Dockrell
Journal:  J Immunol Methods       Date:  2002-06-01       Impact factor: 2.303

View more
  8 in total

1.  Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosis.

Authors:  Sylvie Bertholet; David J Horne; Elsa M Laughlin; Margery Savlov; Ines Tucakovic; Rhea N Coler; Masahiro Narita; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2011-06-29

Review 2.  Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis.

Authors:  Keertan Dheda; Tawanda Gumbo; Neel R Gandhi; Megan Murray; Grant Theron; Zarir Udwadia; G B Migliori; Robin Warren
Journal:  Lancet Respir Med       Date:  2014-03-24       Impact factor: 30.700

3.  A subset of circulating blood mycobacteria-specific CD4 T cells can predict the time to Mycobacterium tuberculosis sputum culture conversion.

Authors:  Catherine Riou; Clive M Gray; Masixole Lugongolo; Thabisile Gwala; Agano Kiravu; Pamela Deniso; Lynsey Stewart-Isherwood; Shaheed Vally Omar; Martin P Grobusch; Gerrit Coetzee; Francesca Conradie; Nazir Ismail; Gilla Kaplan; Dorothy Fallows
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

4.  Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB.

Authors:  Sen Wang; Yang Li; Yaojie Shen; Jing Wu; Yan Gao; Shu Zhang; Lingyun Shao; Jialin Jin; Ying Zhang; Wenhong Zhang
Journal:  J Transl Med       Date:  2018-07-20       Impact factor: 5.531

5.  Serum level of IL-1ra was associated with the treatment of latent tuberculosis infection in a Chinese population.

Authors:  Haoran Zhang; Xuefang Cao; Henan Xin; Jianmin Liu; Shouguo Pan; Ling Guan; Fei Shen; Zisen Liu; Dakuan Wang; Xueling Guan; Jiaoxia Yan; Boxuan Feng; Na Li; Qi Jin; Lei Gao
Journal:  BMC Infect Dis       Date:  2020-05-08       Impact factor: 3.090

6.  The Association Between Mycobacteria-Specific Antigen-Induced Cytokines and Host Response to Latent Tuberculosis Infection Treatment in a Chinese Population.

Authors:  Xuefang Cao; Henan Xin; Haoran Zhang; Jianmin Liu; Shouguo Pan; Ying Du; Boxuan Feng; Zhusheng Quan; Ling Guan; Fei Shen; Zisen Liu; Dakuan Wang; Bin Zhang; Xueling Guan; Jiaoxia Yan; Qi Jin; Lei Gao
Journal:  Front Microbiol       Date:  2021-08-13       Impact factor: 5.640

7.  Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis.

Authors:  Peijun Tang; Xingnian Chen; Junchi Xu; Yunlong Hu; Zhijian Ye; Xiafang Wang; Yumei Xiao; Xinghua Shen; Jianping Zhang; Yanjun Feng; Cuilin Shi; Xin Yu; Lixian Yi; Xinchun Chen; Binfeng Lu; Ping Xu; Zhongwen Sun; Meiying Wu
Journal:  J Immunol Res       Date:  2022-03-17       Impact factor: 4.818

8.  Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy.

Authors:  Ah Young Leem; Joo Han Song; Eun Hye Lee; Hyejon Lee; Bora Sim; Song Yee Kim; Kyung Soo Chung; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Joon Chang; Young Ae Kang
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.